Quick Answer
Niagen Bioscience, Inc. reported Total Assets of $106.41 million for fiscal year 2025.
Niagen Bioscience, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $106.41M | +55.8% |
| 2024 | $68.28M | +24.2% |
| 2023 | $54.96M | +1.7% |
| 2022 | $54.06M | -6.5% |
| 2021 | $57.84M | +50.8% |
| 2020 | $38.36M | -4.7% |
| 2019 | $40.25M | -4.7% |
| 2018 | $42.23M | -32.7% |
| 2017 | $62.72M | +217.6% |
| 2016 | $19.75M | +5.3% |
| 2015 | $18.75M | +62.8% |
| 2014 | $11.52M | +28.2% |
| 2013 | $8.99M | -0.5% |
| 2012 | $9.03M | +44.1% |
| 2011 | $6.27M | -3.6% |
| 2010 | $6.51M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $98.14M | +73.6% | +7.2% |
| June 30, 2025 | $91.53M | +69.4% | +12.5% |
| March 31, 2025 | $81.34M | +50.4% | +19.1% |
| December 31, 2024 | $68.28M | +24.2% | +20.8% |
| September 30, 2024 | $56.52M | +5.7% | +4.6% |
| June 30, 2024 | $54.03M | +1.6% | -0.1% |
| March 31, 2024 | $54.08M | +0.6% | -1.6% |
| December 31, 2023 | $54.96M | +1.7% | +2.8% |
- Niagen Bioscience, Inc. showed an increase of +55.8% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Niagen Bioscience, Inc.’s total assets has grown by 1535.2% (from $6.51 million to $106.41 million).
- The most recent figure is from Niagen Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: